Dr A C Allison (Clinical Research Centre Laboratories, National Institutefor Medical Research, Mill Hill, London NW7) Are Observations on Tumour Viruses in Animals Applicable to Man? There is now abundant evidence that viruses of several different groups (leukemogenic viruses, papovaviruses, poxviruses and adenoviruses) can, when injected into highly susceptible animals, produce tumours. Whether viruses also cause cancer in man is a tantalizing question. For decades it has seemed that the solution must be only just out of reach and that as our reach is extended by modern knowledge and techniques the solution must come within our grasp. And yet we are still without an answer to this simple and fundamental question.
Viruses Causing Benign Tumours in Man The human papilloma virus was one of the first viruses to be studied experimentally and shown to produce warts after infection with cell-free filtrates (see Rowson & Mahy 1967) . These viruses can produce a variety of papillomas, including laryngeal papilloma and condyloma acuminata, but at present there is no evidence that they cause tumours of any other type in man. However, the corresponding viruses in other species can give rise to malignant tumours, e.g. rabbit papilloma virus sometimes produces carcinomas (Rous & Beard 1938) and the bovine papilloma virus when inoculated into newborn hamsters produces transplantable sarcomas (Allison 1965 ). Hence it is quite possible that the seemingly benign human papilloma virus might, under certain conditions, produce malignant tumours in man. Studies of 'T' antigens in this system might provide evidence of such a relationship, but this has not yet been systematically carried out.
There has been much speculation about the role of immunity in regression of warts (see Rowson & Mahy 1967) , and the preliminary report of Spencer (1969) that warts are commoner in patients on immunosuppressive therapy than in comparable untreated subjects is of some interest. Further observations would be worth while.
The other viruses known to produce benign growths in man are poxviruses. These include the molluscum contagiosum virus, which can transmit the associated papillomas experimentally (see Warren 1965) . The Yaba virus is a poxvirus, isolated from rhesus monkeys in Nigeria, which produces histiocytomas after subcutaneous or intravenous inoculation into monkeys (see Andrewes et al. 1959) . Yaba virus, inoculated into human volunteers with advanced cancer, and in one accidental laboratory infection, induced tumours -histologically similar to those in the monkeys -which eventually regressed or were removed surgically, without recurrence (Grace & Mirand 1963) . This is one of three viruses known to produce benign tumours in man. Although in immunologically mature animals oncogenic poxviruses induce regressing lesions, in newtorn rabbits the fibroma virus does not elicit any detectable cell-mediated immunity and the tumours grow to enormous size, spread to distant sites and kill the animals (Allison 1965 ). Hence a virus of this type might produce a continuously growing tumour in subjects whose immune responses are imperfect. This point is discussed further below.
Induction of Tumouirs in Animals
Several of the tumours a-rising spontaneously in laboratory or domestic animals, such as the leukemias of mice or fowls, can be transmitted by viruses under natural conditions. The same is true of the Bittner agent, passed through the milk, which under the appropriate hormonal conditions induces mammary cancer in mice. Another example is the lymphoma in chickens known as
Marek's disease, which has been shown to be due to a herpesvirus (Churchill & Biggs 1967) .
However, some viruses that can cause a variety of tumours when injected in high concentrations into newborn mice very rarelyif everproduce tumours under natural conditions. Instead they give rise to mild infections which spread in a harmless way through colonies of laboratory or wild mice and can only be detected by isolation of virus or the presence of antibody. An example is the polyoma virus, the capacity of which to produce tumours in the adult is limited by an immune response of the host.
These findings present us with the first of our difficulties of interpretation. Laboratory infection of susceptible newborn animals, such as mice or golden hamsters, with large quantities of virus is a highly artificial situation. Finding that tumours are produced in this way certainly shows that the viruses concerned can be oncogenic under certain conditions. The question remains under what range of conditions they will produce tumours, and whether this range ever includes man. The question became especially important when it was recognized that viruses isolated from human subjects can induce malignant tumours under the same special conditions. Several types of human adenovirus (Types 3, 7, 11, 12 and 31) have this property. One approach to this question is to look for antibodies against 'T' antigens of oncogenic adenoviruses in patients with specific tumours. We thought that tumours of the postnasal space in East Africans might be interesting from this point of view, because of their situation and the fact that they can resemble histologically those produced by adenoviruses. However, antibodies against oncogenic adenoviruses or the corresponding 'T' antigens were no more frequent in this group than in controls from the same area. Other workers have had similar experiences with many different tumours, and there is no evidence at present to suggest that adenoviruses are oncogenic in man. We also attempted to induce tumours by inoculating adenovirus Type 12 directly into monkey fetuses, since these might be immunologically immature, but without success.
Antigens in Human Tumours
The presence of antigens in animal tumours has been discussed by Harris in the preceding paper (p 344). Evidence is accumulating that such antigens are also present in human tumours. Among the recent examples is the finding by Morton & Malmgren (1968) of a high incidence of antibodies to osteosarcomas in sera of patients with the disease and their near relatives which react with a common antigen or antigens in osteosarcomas. Hellstrom, Hellstrom, Pierce & Bill (1968) and Hellstr6m, Hellstrom, Pierce & Yang (1968) have reported that neuroblastomas and adenocarcinomas of the colon and lung have tumour-specific antigens against which immunity can be detected by the colony-inhibition assay. Lymphocytes both from patients with tumours and from patients who were free of clinically detectable tumour after therapy were found to inhibit the patients' own tumour cells in vitro. More recently, evidence was obtained (Hellstrom et al. 1969 ) that sera from patients or animals with progressively growing tumours inhibited the in vitro cytotoxicity of the lymphocytes. This is analogous to the enhancement of tumour growth by serum, and may help to explain why tumours can grow despite the presence of lymphocytes capable of producing cell-mediated immune responses.
I have recently discussed the role of immunity in controlling tumour development in animals (Allison 1969) . In experimental animals, especially those that are immunologically mature, the incidence of tumours can be considerably increased and the latent period shortened, by immunosuppressive procedures such as neonatal thymectomy or treatment with antilymphocytic serum.
Indirect evidence suggests that in humans, as well as in animals, oncogenesis is controlled by an immunological surveillance mechanism. It has been found that children with immune deficiency syndromes, and adults on prolonged immunosuppressive therapy after renal homografts, have a much higher incidence of tumours than comparable subjects with no impairment of immunity. The detailed figures will be published by McKhann (1969) and others. Those presented at a iecznt meeting on antilymphocytic serum organized by the National Academy of Sciences and the National Research Council are as follows: More than 200 children with immune deficiency syndromes have been followed up. About 20% of children with the Wiskott-Aldrich syndrome, 10% of those with ataxia-telangiectasia and 10 % of those with other deficiency syndromes, have developed tumours. Sixteen malignant tumours have been observed in adults on immunosuppressive therapy, representing some 2 % of those under observation. The majority have been sarcomas of mesenchymal tissue, especially reticulum cell sarcomas, but 6 carcinomas have also occurred. The incidence of tumours in these subjects is significantly higher than expected by chance, and doubtless more will appear as cases are followed up for longer periods. Several of the tumours appeared in patients receiving azathioprine and prednisone, without antilymphocytic serum.
Thus we are left with the unfortunate fact that as effective immunosuppressive measures are developed and applied for long periods, the risk of impairing the immunological surveillance mechanism against tumours is increased. Now that infections can be reasonably well controlled, this is emerging as the main risk of chronic immunosuppression. These observations imply that in man tumours are often antigenic and their appearance is controlled by an immune reaction.
They do not, of course, necessarily imply that such antigens are due to viruses, although the most potent tumour antigens are those in virusinduced tumours.
Herpesviruses and Tumours
One of the most interesting observations during the past four years was the presence of a herpesvirus (EB virus) in continuous cultures of cells from Burkitt lymphomas (Epstein et al. 1965 ). However, the EB virus has now been associated with infectious mononucleosis (Henle et al. 1967) , and has been found in lymphoid cells cultivated from subjects without tumours. It is not clear whether it actually plays a causal role in the production of Burkitt's lymphomas or is merely a 'passenger' in these cells. The suggestion has been made that infection with the EB virus, in the presence of an intense proliferative stimulus to primitive lymphoid cells, perhaps coupled with some measure of immunosuppression, may be required to produce the Burkitt tumour. Several authors have pointed out that the distribution of Burkitt lymphoma parallels that of holoendemic malaria. Moreover, it has been reported that Burkitt lymphoma occurs less commonly in subjects with sickle-cell hemoglobin (who are protected against severe falciparum malaria) than in those with normal hxemoglobin, and this has been confirmed in Uganda (M C Pike, personal communication). Hence malaria may well be a contributory factor in the etiology of Burkitt's tumour.
It has also been reported that the herpesvirus Type 2 is associated with carcinoma of the cervix (Rawls et al. 1968 ).
Interest in the role of herpesviruses as oncogenic agents has been increased by three findings: First, a virus of this group has been associated with the Lucke renal adenocarcinoma of frogs (Granoff et al. 1965 ). However, the position has been complicated by the more recent finding of other viruses in this system, and it is not clear which of them is the oncogenic agent. There is now substantial evidence supporting the original observations of Churchill & Biggs (1967) that the lymphoproliferative disorder of chickens, Marek's disease, is due to a herpesvirus, and recently immunization with an attenuated virus has been found to confer protection against challenge with virulent virus (Churchill et al. 1969) . The third observation is on a herpesvirus (H. saimiri), isolated from squirrel monkey kidney cells by Melendez et al. (1969) . This produced no lesions when inoculated into the natural host, but when injected into marmosets or owl monkeys induced a reticuloproliferative disorder, with widespread invasion of various organs by reticulum cells. This was thought to be like a reticulum cell sarcoma.
Why has it Proved so Difficult to Isolate Viruses from Human Tumours ? Numerous attempts have been made to isolate viruses from other human malignant tumours, using all the modem techniques of virologyco-cultivation of tumour cells with sensitive indicator cells, and so forth. The few positive results have probably been due to contaminating passenger viruses. The simplest explanation of all these negative results is that the tumours are not induced by viruses at all. However, there are several alternative explanations. One is that human tumour viruses are difficult to isolate and that the correct conditions have not yet been found. This is well known with pathogenic viruses, e.g. some common cold viruses can only be demonstrated in appropriate organ cultures (Tyrrell et al. 1968 ). Another possibility is that human tumour viruses are defective. These are viruses the genomes of which can replicate along with host cells but from which infectious virus cannot be recovered without special techniques.
Examples of this situation in experimental animal tumours have been reviewed by Svoboda (1968) .
One example is the defectiveness of certain strains of Rous sarcoma virus in chickens; another strain of Rous sarcoma virus produces tumours in mammals. The virus cannot be extracted from mammalian cells, but if these cells are cultivated together with chicken cells (especially if the cells are fused to form syncytia) infectious virus develops in the latter. The herpesvirus of Marek's disease has not yet been recovered from disrupted cells, although it can spread from lymphoma cells to kidney cells when they are cultured together (Churchill & Biggs 1967) ; and EB virus appears to behave in a similar way (Henle et al. 1968 ). It has proved difficult to isolate adenoviruses from tumour cells induced by the virus, even though the presence of virus-specific antigens makes it virtually certain that at least part of the viral genome persists in these cells through numerous cycles of division. Hence the failure to isolate oncogenic viruses from human tumours may be merely technicalthe appropriate conditions for identifying such viruses or rescuing defective viruses have not yet been found.
Conclusion
We know that some benign tumours in man are virus-induced, and the EB virus may play a part in the etiology of Burkitt's lymphoma and possibly other lymphoproliferative disorders. Evidence is accumulating that human tumours are antigenic and that their appearance may be controlled by immune reactions of the host. But for the great majority of human tumours, seen in the hospitals every day, we still have no hint about whether they are induced by viruses. The last decade has brought a spectacular increase in our knowledge of induction by viruses of tumours in animals and of the underlying mechanisms, but only modest progress in applying these findings to man.
